{"@context":{"@vocab":"https://cir.nii.ac.jp/schema/1.0/","rdfs":"http://www.w3.org/2000/01/rdf-schema#","dc":"http://purl.org/dc/elements/1.1/","dcterms":"http://purl.org/dc/terms/","foaf":"http://xmlns.com/foaf/0.1/","prism":"http://prismstandard.org/namespaces/basic/2.0/","cinii":"http://ci.nii.ac.jp/ns/1.0/","datacite":"https://schema.datacite.org/meta/kernel-4/","ndl":"http://ndl.go.jp/dcndl/terms/","jpcoar":"https://github.com/JPCOAR/schema/blob/master/2.0/"},"@id":"https://cir.nii.ac.jp/crid/1584231874408872704.json","@type":"Researcher","foaf:Person":[{"foaf:name":[{"@language":"ja","@value":"鄭容錫"}]}],"product":[{"@id":"https://cir.nii.ac.jp/crid/1574231874408872704","@type":"Article","productIdentifier":[{"@type":"NAID","@value":"10008498216"}],"notation":[{"@value":"Biochemical modulator としてのCDDP と 5-FU との combination therapy による進行, 再発消化器癌の治療"}],"relation":[{"type":"creator"}]}],"dataSourceIdentifier":[{"@type":"CIA","@value":"10008498216_RVGNRgfA933ZeP1Ik0b598vuhEU"}]}